Medical Information Only. Consult your healthcare provider before enrolling in any clinical trial.
New Mexico: below-average open trial sites
168 of 579 in-state trials are recruiting (29%); below the 37% national average by 8 percentage points.
According to ClinicalTrials.gov-derived indexes, New Mexico sits in the lower half of US states by in-state trial count (#40 of 52 states by registered in-state trial count).
New Mexico: 579 US clinical trials with in-state sites, 168 recruiting.
New Mexico has 579 registered US clinical trials with a study site in-state, 168 of them currently recruiting (below the 37% national average by 8 percentage points). 137 of these trials are in Phase 3 (late-stage) and 170 in Phase 2. The most frequently studied condition in New Mexico is Breast Cancer, with 18 linked trials.
Thin-volume New Mexico archive
New Mexico open-enrollment share is 29% (p24 of states with sites; national baseline 37%). Treat this page as a compact local index (thin-volume · low-open), then jump to recruiting trials or methodology rather than expecting hub-scale coverage.
Below-average open enrollment
New Mexico still shows 168 recruiting of 579 in-state trials (29% open), but below the 37% national average by 8 percentage points, so archived statuses weigh heavier than the national baseline.
- 29%
- open (below national share)
- 168
- still recruiting despite cool share
- 170
- Phase 2 rows in this footprint
- 18
- top: Breast Cancer
Recruiting share is below the 37% national average by 8 percentage points. Counts include every study with at least one recorded site in the state. Registry reference only, not medical advice.
New Mexico vs all states by indexed in-state trial count
Where this state's ClinicalTrials.gov site count sits among every state with at least one listed trial (coverage density, not care quality)
579 Top 77% more indexed trials than 23% of 52 states
States, banded by indexed in-state trial count
Each bar is a band; taller bars hold more states. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov · 2026-08-08
Key findings
What ClinicalTrials.gov does not surface for New Mexico on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
New Mexico open-enrollment share sits below the national baseline.
168 of 579 in-state trials (29%) are recruiting, against 37% nationally (-8 percentage points). Counts include every study with at least one recorded site in the state.
-
Albuquerque dominates New Mexico's trial geography.
Albuquerque lists 505 of 579 in-state trials (87.2%) across 225 named facilities. Cities need five or more listed trials to appear here; locations are as filed by sponsors.
-
Breast Cancer is the most-studied condition in New Mexico.
18 of 579 in-state trials (3.1%) list Breast Cancer. That is a local concentration figure, not a national disease ranking.
-
One sponsor accounts for a large share of New Mexico trials.
University of New Mexi appears on 73 of 579 in-state trials (12.6%). Sponsor identity is as filed on ClinicalTrials.gov.
-
285 New Mexico trials carry a completed status.
285 of 579 (49.2%) are completed. The open share above is the remainder that still lists recruiting.
By Status
| Status | Trial count |
|---|---|
| Completed | 285 |
| Recruiting | 168 |
| Active | 126 |
By Phase
| Phase | Trial count |
|---|---|
| Phase 2 | 170 |
| NA | 138 |
| Phase 3 | 137 |
| Phase 1 | 43 |
| Phase 4 | 23 |
| Early Phase 1 | 7 |
Top Conditions
Top Sponsors
Where trials run in New Mexico
Albuquerque carries 505 of New Mexico's 579 indexed trials (87%) across 225 named sites, ahead of Santa Fe at 30. 7 cities clear five listed trials, together naming 281 distinct sites.
| City | Trials | Listed sites |
|---|---|---|
| Albuquerque | 505 | 225 |
| Santa Fe | 30 | 19 |
| Gallup | 11 | 11 |
| Las Cruces | 10 | 8 |
| Farmington | 10 | 4 |
| Rio Rancho | 8 | 7 |
| Shiprock | 7 | 7 |
Distinct trials and named sites per city, as filed with ClinicalTrials.gov; cities under five trials omitted. Vintage 2026-08-08.
Open-share low
New Mexico open-enrollment share is 29% (p24 of states with sites; national baseline 37%).
New Mexico: open share sits in the low tercile of states
Geography is concentrated: Albuquerque alone accounts for 87% of New Mexico's indexed trials (505 of 579), with Santa Fe a distant second at 30.
Phase mix: 137 Phase 3 vs 170 Phase 2 (balanced across stages).
Top condition: Breast Cancer (18 trials); top sponsor University of New Mexi (73).
thin-volume · low-open figures (579 trials · 29% open) describe registry geography under the open-share low read, not clinic capacity or protocol fit. Confirm status on ClinicalTrials.gov before acting.
States near New Mexico on open-enrollment share
Cross-state peers under the open-share low read (thin-volume · low-open), not the same-state browse list.
Similar thin-volume peers (± open share)
- Idaho · 633 trials · 26% recruiting
- Delaware · 652 trials · 33% recruiting
- Mississippi · 500 trials · 27% recruiting
- Alaska · 485 trials · 25% recruiting
- New Hampshire · 471 trials · 33% recruiting